{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:10:34Z","timestamp":1762272634976,"version":"3.37.3"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jconrel.2020.08.034","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T16:27:19Z","timestamp":1598372839000},"page":"263-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["An anchoring molecule increases intravitreal retention of antibody-based therapeutics used in the treatment of ocular diseases"],"prefix":"10.1016","volume":"328","author":[{"given":"Quanqing","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira H.","family":"Schachar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.08.034_bb0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","article-title":"Vascular endothelial growth factor a in intraocular vascular disease","volume":"120","author":"Miller","year":"2013","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ophtha.2015.09.035","article-title":"Intravitreal Aflibercept for macular edema following branch retinal vein occlusion: 52-week results of the VIBRANT study","volume":"123","author":"Clark","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2020.08.034_bb0015","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Jaffe, Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"CATT Research Group","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0020","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial","volume":"123","author":"Wells","year":"2016","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/IAE.0b013e318192f574","article-title":"Rituximab for intraocular lymphoma","volume":"29","author":"Itty","year":"2009","journal-title":"Retina."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0030","doi-asserted-by":"crossref","first-page":"975","DOI":"10.4103\/ijo.IJO_1938_18","article-title":"Intravenous tocilizumab in idiopathic pediatric uveitis with refractory cystoid macular edema \u2013 a case report","volume":"67","author":"Babu","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0045","first-page":"695","article-title":"Ocular half-life of intravitreal biologics in humans and other species: meta-analysis and model-based prediction","volume":"17","author":"Caruso","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0050","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2015.06.017","article-title":"Intravitreal Aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies","volume":"122","author":"Brown","year":"2015","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0055","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bjophthalmol-2014-305327","article-title":"Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration","volume":"99","author":"Holz","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0060","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ophtha.2019.03.036","article-title":"The port delivery system with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 ladder clinical trial","volume":"126","author":"Campochiaro","year":"2019","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0065","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.drudis.2019.05.037","article-title":"Hydrogels for sustained delivery of biologics to the back of the eye","volume":"24","author":"Chang","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.08.034_bb0070","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1021\/acs.bioconjchem.9b00475","article-title":"Hyaluronic acid\u2013antibody fragment bioconjugates for extended ocular pharmacokinetics","volume":"30","author":"Famili","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0075","first-page":"114","article-title":"A novel long-acting drug conjugate for extended anti-VEGF therapy","volume":"60","author":"Jackson","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0080","first-page":"3670","article-title":"Phase 1 first-in-human study of KSI-301: a novel anti-VEGF antibody biopolymer conjugate with extended durability","volume":"60","author":"Patel","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0085","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.drudis.2019.05.038","article-title":"Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives","volume":"24","author":"Bordet","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.08.034_bb0090","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S1367-5931(00)00216-7","article-title":"Human antibodies as next generation therapeutics","volume":"5","author":"van Dijk","year":"2001","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0095","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/ma9120994","article-title":"Fc-binding ligands of immunoglobulin G: an overview of high affinity proteins and peptides","volume":"9","author":"Choe","year":"2016","journal-title":"Materials."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF00170555","article-title":"An immunochemical quantitative analysis of the protein pattern in physiologic and pathologic vitreous","volume":"229","author":"Clausen","year":"1991","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0105","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1167\/iovs.17-22160","article-title":"Sustaining intravitreal residence with L-arginine peptide-conjugated nanocarriers","volume":"58","author":"Li","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","article-title":"Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo","volume":"167","author":"Xu","year":"2013","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0115","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.ophtha.2008.04.023","article-title":"Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization","volume":"115","author":"Zhu","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2020.08.034_bb0120","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/j.bios.2007.03.003","article-title":"Concentration dependence of IgG\u2013protein A affinity studied by wireless-electrodeless QCM","volume":"22","author":"Ogi","year":"2007","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0014-4835(83)90043-X","article-title":"Turnover of hyaluronate in the aqueous humour and vitreous body of the rabbit","volume":"36","author":"Laurent","year":"1983","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2020.08.034_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007507","article-title":"Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography","volume":"4","author":"Fischer","year":"2009","journal-title":"PLoS One"},{"year":"2006","author":"Heckenlively","series-title":"Principles and Practice of Clinical Electrophysiology of Vision","key":"10.1016\/j.jconrel.2020.08.034_bb0140"},{"key":"10.1016\/j.jconrel.2020.08.034_bb0145","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jcpa.2014.07.003","article-title":"Immunohistochemical expression of ionized calcium binding adapter molecule 1 in cutaneous histiocytic proliferative, neoplastic and inflammatory disorders of dogs and cats","volume":"151","author":"Pierezan","year":"2014","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218613","article-title":"Identification and characterization of an octameric PEG-protein conjugate system for intravitreal long-acting delivery to the back of the eye","volume":"14","author":"Shatz","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2020.08.034_bb0160","first-page":"211","article-title":"KSI-301: an anti-VEGF antibody biopolymer conjugate with extended half-life for treatment of neovascular retinal diseases","volume":"59","author":"Liang","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0165","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.287.5456.1279","article-title":"Convergent solutions to binding at a protein-protein interface","volume":"287","author":"DeLano","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2020.08.034_bb0170","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1046\/j.1365-2567.1996.d01-692.x","article-title":"Crystallization of a complex between the Fab fragment of a human immunoglobulin M (IgM) rheumatoid factor (RF\u2013AN) and the Fc fragment of human IgG4","volume":"88","author":"Sohi","year":"1996","journal-title":"Immunology."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0175","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1021\/acs.bioconjchem.6b00170","article-title":"Development of the double cyclic peptide ligand for antibody purification and protein detection","volume":"27","author":"Gong","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0180","first-page":"33","article-title":"Characterization and transplantation of agarose microencapsulated canine islets of Langerhans","volume":"2","author":"Tashiro","year":"1997","journal-title":"Ann. Transplant."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-3659(01)00214-0","article-title":"Lipid-based microtubular drug delivery vehicles","volume":"71","author":"Meilander","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.08.034_bb0190","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archopht.1979.01020020075018","article-title":"Drainage of microspheres and RBCs from the vitreous of aphakic and phakic eyes","volume":"97","author":"Algvere","year":"1979","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0195","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2014.0817","article-title":"Natural polymers for the microencapsulation of cells","volume":"11","author":"Gasperini","year":"2014","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.jconrel.2020.08.034_bb0200","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.biomaterials.2010.09.044","article-title":"A functionalizable reverse thermal gel based on a polyurethane\/PEG block copolymer","volume":"32","author":"Park","year":"2011","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/02713683.2018.1533983","article-title":"Biodegradable microsphere-hydrogel ocular drug delivery system for controlled and extended release of bioactive aflibercept in vitro","volume":"44","author":"Liu","year":"2019","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10456-004-8272-2","article-title":"Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro","volume":"7","author":"Wang","year":"2004","journal-title":"Angiogenesis."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0215","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006406","article-title":"Two year result of intravitreal bevacizumab for diabetic macular edema using treat and extend protocol","volume":"96","author":"Sugimoto","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jconrel.2020.08.034_bb0220","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/IAE.0000000000000134","article-title":"Anti-vegf treatment in neovascular age\u2013related macular degeneration: a treat-and-extend protocol over 2 years","volume":"34","author":"Abedi","year":"2014","journal-title":"RETINA."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1208\/s12248-009-9157-5","article-title":"Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease","volume":"12","author":"Tabrizi","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0230","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1167\/iovs.02-1027","article-title":"Human retinal molecular weight exclusion limit and estimate of species variation","volume":"44","author":"Jackson","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0235","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/nprot.2013.121","article-title":"Site-specific chemical modification of antibody fragments using traceless cleavable linkers","volume":"8","author":"Bernardes","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17040561","article-title":"Linkers having a crucial role in antibody\u2013drug conjugates","volume":"17","author":"Lu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0245","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.molimm.2004.09.015","article-title":"Immune complement activation on polystyrene and silicon dioxide surfaces: impact of reversible IgG adsorption","volume":"42","author":"Sellborn","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0250","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000118928","article-title":"Postnatal developmental changes of vitreous and lens volumes in Sprague-Dawley rats","volume":"4","author":"Sha","year":"2006","journal-title":"Neuroembryology Aging."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0255","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bjo.74.3.160","article-title":"Immunoglobulins in paired specimens of vitreous and subretinal fluids from patients with rhegmatogenous retinal detachment","volume":"74","author":"Rose","year":"1990","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0260","first-page":"293","article-title":"Elevated vitreous concentration of monoclonal immunoglobulin manifesting as schlieren in Juvenile Rheumatoid Arthritis\u2013Associated Uveitis","volume":"119","author":"Nguyen","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0265","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1076\/ceyr.22.1.74.6974","article-title":"Quantitative analysis of intravitreal injections in the rat","volume":"22","author":"Dureau","year":"2001","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0270","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2147\/OPTH.S82562","article-title":"Sterile endophthalmitis rates and particle size analyses of different formulations of triamcinolone acetonide","volume":"9","author":"Dodwell","year":"2015","journal-title":"Clin. Ophthalmol. Auckl. NZ."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0275","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ajo.2006.03.042","article-title":"Patient perceptions of discomfort and changes in vision and functional status associated with intravitreal triamcinolone injection","volume":"142","author":"Roth","year":"2006","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0280","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.carbpol.2012.02.050","article-title":"Synthesis and characterization of a degradable composite agarose\/HA hydrogel","volume":"88","author":"Zhang","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0285","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jcis.2007.02.040","article-title":"Preparation of uniform-sized agarose beads by microporous membrane emulsification technique","volume":"311","author":"Zhou","year":"2007","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2020.08.034_bb0290","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/app.34731","article-title":"A library of tunable agarose carbomer-based hydrogels for tissue engineering applications: the role of cross-linkers","volume":"123","author":"Rossi","year":"2012","journal-title":"J. Appl. Polym. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920304752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920304752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:12:55Z","timestamp":1718421175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920304752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":57,"alternative-id":["S0168365920304752"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.034","relation":{},"ISSN":["0168-3659"],"issn-type":[{"type":"print","value":"0168-3659"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An anchoring molecule increases intravitreal retention of antibody-based therapeutics used in the treatment of ocular diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}